MicroRNAs in prostate cancer: Functional role as biomarkers

Cancer Lett. 2017 Oct 28:407:9-20. doi: 10.1016/j.canlet.2017.08.011. Epub 2017 Aug 18.

Abstract

MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene expression through post-transcriptional regulation of messenger RNA. Compelling evidence suggest the role of miRNA in cancer biology having potential as diagnostic, prognostic and predictive biomarkers. This review summarizes the current knowledge on miRNA deregulated in prostate cancer and their role as oncogene, tumor suppressor and metastasis regulators. The emerging information elucidating the biological function of miRNA is promising and may lead to their potential usefulness as diagnostic/prognostic markers and development as effective therapeutic tools for management of prostate cancer.

Keywords: Androgen receptor; Biomarkers; Castrate-resistant prostate cancer; Non-coding RNA; Oncomirs; Tumor suppressor.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • MicroRNAs / metabolism
  • MicroRNAs / physiology*
  • Prognosis
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / metabolism*

Substances

  • Biomarkers, Tumor
  • MicroRNAs